209 related articles for article (PubMed ID: 8943844)
1. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.
Iida S; Rao PH; Nallasivam P; Hibshoosh H; Butler M; Louie DC; Dyomin V; Ohno H; Chaganti RS; Dalla-Favera R
Blood; 1996 Dec; 88(11):4110-7. PubMed ID: 8943844
[TBL] [Abstract][Full Text] [Related]
2. t(9;14)(p13;q32) involving the PAX-5 gene: a unique subtype of 14q32 translocation in B cell non-Hodgkin's lymphoma.
Amakawa R; Ohno H; Fukuhara S
Int J Hematol; 1999 Feb; 69(2):65-9. PubMed ID: 10071452
[TBL] [Abstract][Full Text] [Related]
3. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.
Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M
Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).
Iida S; Rao PH; Ueda R; Chaganti RS; Dalla-Favera R
Leuk Lymphoma; 1999 Jun; 34(1-2):25-33. PubMed ID: 10350329
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.
Busslinger M; Klix N; Pfeffer P; Graninger PG; Kozmik Z
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6129-34. PubMed ID: 8650231
[TBL] [Abstract][Full Text] [Related]
6. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M
Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21.
Willis TG; Zalcberg IR; Coignet LJ; Wlodarska I; Stul M; Jadayel DM; Bastard C; Treleaven JG; Catovsky D; Silva ML; Dyer MJ
Blood; 1998 Mar; 91(6):1873-81. PubMed ID: 9490669
[TBL] [Abstract][Full Text] [Related]
8. Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry.
Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Takeoka K; Hayashida M; Sakamoto S; Akasaka T; Honjo G
Hematol Oncol; 2020 Apr; 38(2):171-180. PubMed ID: 31955451
[TBL] [Abstract][Full Text] [Related]
9. The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
Ohno H; Ueda C; Akasaka T
Leuk Lymphoma; 2000 Feb; 36(5-6):435-45. PubMed ID: 10784387
[TBL] [Abstract][Full Text] [Related]
10. A case of primary splenic large cell lymphoma with a t(9;14)(p13;q32).
Kawakami K; Amakawa R; Miyanishi S; Okumura A; Hayashi T; Kurata M; Ohno H; Ohno Y; Fukuhara S
Int J Hematol; 1998 Feb; 67(2):191-8. PubMed ID: 9631587
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
Souabni A; Jochum W; Busslinger M
Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
[TBL] [Abstract][Full Text] [Related]
12. Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.
George TI; Wrede JE; Bangs CD; Cherry AM; Warnke RA; Arber DA
J Mol Diagn; 2005 Aug; 7(3):346-51. PubMed ID: 16049306
[TBL] [Abstract][Full Text] [Related]
13. Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization.
Taniwaki M; Nishida K; Ueda Y; Misawa S; Nagai M; Tagawa S; Yamagami T; Sugiyama H; Abe M; Fukuhara S
Blood; 1995 Jun; 85(11):3223-8. PubMed ID: 7756653
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific rearrangements of the immunoglobulin heavy-chain gene in B-cell non-Hodgkin's lymphoma detected by in situ hybridization.
Ueda Y; Matsuda F; Misawa S; Taniwaki M
Blood; 1996 Jan; 87(1):292-8. PubMed ID: 8547654
[TBL] [Abstract][Full Text] [Related]
15. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
[TBL] [Abstract][Full Text] [Related]
16. t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.
Ohno H; Takeoka K; Kishimori C; Nakagawa M; Fukutsuka K; Maekawa F; Hayashida M; Akasaka T; Sumiyoshi S
J Clin Exp Hematop; 2021 Dec; 61(4):216-220. PubMed ID: 34707037
[TBL] [Abstract][Full Text] [Related]
17. In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes.
Daibata M; Taguchi T; Nemoto Y; Iwasaki S; Ohtsuki Y; Taguchi H
Int J Cancer; 2006 Jan; 118(2):513-7. PubMed ID: 16049984
[TBL] [Abstract][Full Text] [Related]
18. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).
Cook JR; Aguilera NI; Reshmi-Skarja S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH
Hum Pathol; 2004 Apr; 35(4):447-54. PubMed ID: 15116325
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.
Ye BH; Chaganti S; Chang CC; Niu H; Corradini P; Chaganti RS; Dalla-Favera R
EMBO J; 1995 Dec; 14(24):6209-17. PubMed ID: 8557040
[TBL] [Abstract][Full Text] [Related]
20. Identification of IGHCδ-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia.
Kobayashi S; Taki T; Chinen Y; Tsutsumi Y; Ohshiro M; Kobayashi T; Matsumoto Y; Kuroda J; Horiike S; Nishida K; Taniwaki M
Genes Chromosomes Cancer; 2011 Apr; 50(4):207-16. PubMed ID: 21319257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
